releases: https://rohrabacher.house.gov/media-center/press-releases/rohrabacher-blumenauer-urge-lawmakers-to-keep-medical-marijuana

One row per release. Full-text search runs over title + body text.

Data license: MIT · Data source: dwillis/congress-press

This data as json

url title date year month party chamber state member_name bioguide_id domain scraper source date_source text has_text collected_at updated_at
https://rohrabacher.house.gov/media-center/press-releases/rohrabacher-blumenauer-urge-lawmakers-to-keep-medical-marijuana Rohrabacher, Blumenauer Urge Lawmakers to Keep Medical Marijuana Protections 2017-11-30 2017 2017-11 Republican House CA Dana Rohrabacher R000409 rohrabacher.house.gov     legacy WASHINGTON – Representatives Dana Rohrabacher, R-CA, and Earl Blumenauer, D-OR, led a bipartisan group of lawmakers urging House and Senate leadership to continue state medical marijuana protections in any legislation to fund the government beyond Dec. 8, 2017. The Rohrabacher-Blumenauer provision prevents the Department of Justice from interfering with state medical marijuana laws. In a letter to Speaker Ryan, Leader McConnell, Leader Pelosi and Leader Schumer, the lawmakers wrote: “The provision, which first became law in December 2014, has successfully protected patients, providers, and businesses against federal prosecution, so long as they act within the confines of their state’s medical marijuana laws. These protections extend to 46 states, the District of Columbia, Guam, and Puerto Rico, all of which allow some form of medical marijuana that is strictly prohibited by the federal government—from CBD oils to the full plant. The language is supported by a bipartisan majority of the House, last passing as a standalone provision by a vote of 242-186 in 2015.” The full text of the letter and signatories is below. Click here for an electronic copy.   November 28, 2017   The Honorable Paul Ryan                                                                 The Honorable Mitch McConnell Speaker                                                                                                 Majority Leader U.S. House of Representatives                                                        U.S. Senate 1233 Longworth House Office Building                                         317 Russell Senate Office Building Washington, D.C.  20515                                                                  Washington, D.C.  20510   The Honorable Nancy Pelosi                                                            The Honorable Charles Schumer Democratic Leader                                                                            Democratic Leader U.S. House of Representatives                                                        U.S. Senate 233 Cannon House Office building                                                  322 Hart Senate Office Building Washington, D.C.  20515                                                                  Washington, D.C.  20510                    Dear Speaker Ryan, Leader McConnell, Leader Pelosi, and Leader Schumer: As you work with the Appropriations Committees to negotiate a fiscal year (FY) 2018 appropriations bill to fund the government beyond December 8, 2017, we write to express our support for the inclusion of a provision that provides protections from the federal government to states that have medical marijuana laws on the books. The provision, which first became law in December 2014, has successfully protected patients, providers, and businesses against federal prosecution, so long as they act within the confines of their state’s medical marijuana laws.  These protections extend to 46 states, the District of Columbia, Guam, and Puerto Rico, all of which allow some form of medical marijuana that is strictly prohibited by the federal government—from CBD oils to the full plant.  The language is supported by a bipartisan majority of the House, last passing as a standalone provision by a vote of 242-186 in 2015. Specifically, we urge you to include in any final negotiated package the language adopted by the Senate Appropriations Committee in July by voice vote during their markup of the FY ’18 CJS appropriations bill:  None of the funds made available under this Act to the Department of Justice may be used, with respect to any of the States of Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, Florida, Georgia, Hawaii, Illinois, Indiana, Iowa, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, Wisconsin, and Wyoming, or with respect to the District of Columbia, Guam, or Puerto Rico, to prevent any such State or jurisdiction from implementing a law that authorizes the use, distribution, possession, or cultivation of medical marijuana. We appreciate the difficult task before you.  Thank you for your attention to this important matter.   Sincerely,   ###   Kenneth Grubbs, 202-225-2415 1 2026-03-30T12:14:52Z 2026-03-30T12:14:52Z